$84.92
1.48% yesterday
Nasdaq, Dec 03, 10:00 pm CET

LeMaitre Vascular, Inc. Stock price

$84.92
-2.00 2.30% 1M
+2.06 2.49% 6M
-7.22 7.84% YTD
-20.10 19.14% 1Y
+38.91 84.57% 3Y
+48.35 132.21% 5Y
+70.31 481.25% 10Y
+78.72 1,269.68% 20Y
Nasdaq, Closing price Wed, Dec 03 2025
+1.24 1.48%

New AI Insights on LeMaitre Vascular, Inc. Insights AI Insights on LeMaitre Vascular, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$1.8b
Net debt
positive
Cash
$343.1m
Shares outstanding
22.7m
Valuation (TTM | estimate)
P/E
39.0 | 36.5
P/S
8.0 | 7.5
EV/Sales
7.3 | 6.9
EV/FCF
26.5
P/B
5.1
Dividends
DPS
$0.80
Yield 1Y | 5Y
0.9% | 0.9%
Growth 1Y | 5Y
25.0% | 16.1%
Payout 1Y | 3Y
33.2% | 40.5%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$240.9m | $255.6m
EBITDA
$67.6m | $77.3m
EBIT
$61.9m | $61.9m
Net Income
$53.3m | $52.8m
Free Cash Flow
$66.2m
Growth (TTM | estimate)
Revenue
13.1% | 16.3%
EBITDA
21.8% | 33.2%
EBIT
24.8% | 18.4%
Net Income
29.1% | 19.8%
Free Cash Flow
97.8%
Margin (TTM | estimate)
Gross
71.0%
EBITDA
28.1% | 30.3%
EBIT
25.7%
Net
22.1% | 20.6%
Free Cash Flow
27.5%
Financial Health
Equity Ratio
61.1%
Return on Equity
13.1%
ROCE
11.0%
ROIC
19.2%
Debt/Equity
0.4
More
EPS
$2.2
FCF per Share
$2.9
Short interest
7.0%
Employees
658
Rev per Employee
$330.0k
Show more

Is LeMaitre Vascular, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

LeMaitre Vascular, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a LeMaitre Vascular, Inc. forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a LeMaitre Vascular, Inc. forecast:

Buy
63%
Hold
38%

Financial data from LeMaitre Vascular, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
241 241
13% 13%
100%
- Direct Costs 70 70
4% 4%
29%
171 171
17% 17%
71%
- Selling and Administrative Expenses 89 89
21% 21%
37%
- Research and Development Expense 14 14
13% 13%
6%
68 68
22% 22%
28%
- Depreciation and Amortization 5.68 5.68
4% 4%
2%
EBIT (Operating Income) EBIT 62 62
25% 25%
26%
Net Profit 53 53
29% 29%
22%

In millions USD.

Don't miss a Thing! We will send you all news about LeMaitre Vascular, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LeMaitre Vascular, Inc. Stock News

Neutral
GlobeNewsWire
22 days ago
BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.
Neutral
Seeking Alpha
27 days ago
LeMaitre Vascular, Inc. ( LMAT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Dorian LeBlanc - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - President & Director Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Shaymus Contorno - Oppenheimer & Co. Inc., Research Division Rick Wise Nathan Treybeck - Wells Fargo ...
Neutral
GlobeNewsWire
28 days ago
BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.
More LeMaitre Vascular, Inc. News

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Head office United States
CEO George LeMaitre
Employees 658
Founded 1983
Website www.lemaitre.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today